ArticleESMO open2020

Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10.

Stacy Grieve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.